SIGA TECHNOLOGIES INC (SIGA) Stock Fundamental Analysis
NASDAQ:SIGA - Nasdaq - US8269171067 - Common Stock - Currency: USD
Taking everything into account, SIGA scores 7 out of 10 in our fundamental rating. SIGA was compared to 197 industry peers in the Pharmaceuticals industry. SIGA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. SIGA scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings would make SIGA suitable for value and quality investing!
1. Profitability
1.1 Basic Checks
SIGA had positive earnings in the past year.
SIGA had a positive operating cash flow in the past year.
In the past 5 years SIGA has always been profitable.
Each year in the past 5 years SIGA had a positive operating cash flow.
1.2 Ratios
SIGA has a better Return On Assets (24.23%) than 98.98% of its industry peers.
With an excellent Return On Equity value of 27.44%, SIGA belongs to the best of the industry, outperforming 95.43% of the companies in the same industry.
With an excellent Return On Invested Capital value of 24.83%, SIGA belongs to the best of the industry, outperforming 96.45% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SIGA is significantly below the industry average of 40.40%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.23% | ||
| ROE | 27.44% | ||
| ROIC | 24.83% |
ROA(3y)22.79%
ROA(5y)27.67%
ROE(3y)27.31%
ROE(5y)33.04%
ROIC(3y)25.54%
ROIC(5y)32.27%
1.3 Margins
With an excellent Profit Margin value of 42.69%, SIGA belongs to the best of the industry, outperforming 98.98% of the companies in the same industry.
In the last couple of years the Profit Margin of SIGA has declined.
SIGA has a Operating Margin of 50.45%. This is amongst the best in the industry. SIGA outperforms 98.98% of its industry peers.
In the last couple of years the Operating Margin of SIGA has declined.
SIGA has a better Gross Margin (77.44%) than 83.76% of its industry peers.
In the last couple of years the Gross Margin of SIGA has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 50.45% | ||
| PM (TTM) | 42.69% | ||
| GM | 77.44% |
OM growth 3Y-8.86%
OM growth 5YN/A
PM growth 3Y-6.36%
PM growth 5YN/A
GM growth 3Y-4.02%
GM growth 5Y-3.73%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SIGA is creating value.
SIGA has more shares outstanding than it did 1 year ago.
SIGA has less shares outstanding than it did 5 years ago.
SIGA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
SIGA has an Altman-Z score of 11.39. This indicates that SIGA is financially healthy and has little risk of bankruptcy at the moment.
SIGA's Altman-Z score of 11.39 is amongst the best of the industry. SIGA outperforms 89.85% of its industry peers.
There is no outstanding debt for SIGA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 11.39 |
ROIC/WACC2.56
WACC9.68%
2.3 Liquidity
SIGA has a Current Ratio of 9.12. This indicates that SIGA is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 9.12, SIGA belongs to the best of the industry, outperforming 81.73% of the companies in the same industry.
SIGA has a Quick Ratio of 7.16. This indicates that SIGA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 7.16, SIGA is in the better half of the industry, outperforming 77.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 9.12 | ||
| Quick Ratio | 7.16 |
3. Growth
3.1 Past
SIGA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.68%.
The Earnings Per Share has been decreasing by -3.27% on average over the past years.
Looking at the last year, SIGA shows a decrease in Revenue. The Revenue has decreased by -0.83% in the last year.
SIGA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 39.04% yearly.
EPS 1Y (TTM)-13.68%
EPS 3Y-3.27%
EPS 5YN/A
EPS Q2Q%-37.62%
Revenue 1Y (TTM)-0.83%
Revenue growth 3Y1.24%
Revenue growth 5Y39.04%
Sales Q2Q%-30.12%
3.2 Future
Based on estimates for the next years, SIGA will show a very strong growth in Earnings Per Share. The EPS will grow by 45.42% on average per year.
The Revenue is expected to grow by 21.74% on average over the next years. This is a very strong growth
EPS Next Y-16.66%
EPS Next 2Y45.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-24.13%
Revenue Next 2Y21.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 7.30, the valuation of SIGA can be described as very cheap.
93.40% of the companies in the same industry are more expensive than SIGA, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of SIGA to the average of the S&P500 Index (28.29), we can say SIGA is valued rather cheaply.
The Price/Forward Earnings ratio is 8.76, which indicates a very decent valuation of SIGA.
SIGA's Price/Forward Earnings ratio is rather cheap when compared to the industry. SIGA is cheaper than 89.34% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.08. SIGA is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.3 | ||
| Fwd PE | 8.76 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SIGA is valued cheaper than 96.95% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, SIGA is valued cheaply inside the industry as 90.86% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.78 | ||
| EV/EBITDA | 3.86 |
4.3 Compensation for Growth
The decent profitability rating of SIGA may justify a higher PE ratio.
SIGA's earnings are expected to grow with 45.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.42%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 10.02%, SIGA is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.57, SIGA pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.02% |
5.2 History
SIGA has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
SIGA pays out 72.05% of its income as dividend. This is not a sustainable payout ratio.
DP72.05%
EPS Next 2Y45.42%
EPS Next 3YN/A
5.99
+0.07 (+1.18%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners51.54%
Inst Owner Change0%
Ins Owners8.66%
Ins Owner Change1.74%
Market Cap427.93M
Analysts0
Price TargetN/A
Short Float %10.12%
Short Ratio9.25
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.02% |
Yearly Dividend0.6
Dividend Growth(5Y)N/A
DP72.05%
Div Incr Years1
Div Non Decr Years2
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-46.83%
EPS NY rev (3m)-46.83%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-34.07%
Revenue NY rev (3m)-34.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.3 | ||
| Fwd PE | 8.76 | ||
| P/S | 3.08 | ||
| P/FCF | 8.78 | ||
| P/OCF | 8.78 | ||
| P/B | 1.98 | ||
| P/tB | 1.99 | ||
| EV/EBITDA | 3.86 |
EPS(TTM)0.82
EY13.69%
EPS(NY)0.68
Fwd EY11.41%
FCF(TTM)0.68
FCFY11.39%
OCF(TTM)0.68
OCFY11.39%
SpS1.94
BVpS3.02
TBVpS3.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.23% | ||
| ROE | 27.44% | ||
| ROCE | 31.96% | ||
| ROIC | 24.83% | ||
| ROICexc | 85.49% | ||
| ROICexgc | 86.71% | ||
| OM | 50.45% | ||
| PM (TTM) | 42.69% | ||
| GM | 77.44% | ||
| FCFM | 35.12% |
ROA(3y)22.79%
ROA(5y)27.67%
ROE(3y)27.31%
ROE(5y)33.04%
ROIC(3y)25.54%
ROIC(5y)32.27%
ROICexc(3y)86.84%
ROICexc(5y)130.54%
ROICexgc(3y)88.23%
ROICexgc(5y)134.25%
ROCE(3y)32.88%
ROCE(5y)41.53%
ROICexcg growth 3Y0.15%
ROICexcg growth 5YN/A
ROICexc growth 3Y0.05%
ROICexc growth 5YN/A
OM growth 3Y-8.86%
OM growth 5YN/A
PM growth 3Y-6.36%
PM growth 5YN/A
GM growth 3Y-4.02%
GM growth 5Y-3.73%
F-Score5
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 7.89% | ||
| Cap/Sales | 0.03% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 69.14% | ||
| Profit Quality | 82.28% | ||
| Current Ratio | 9.12 | ||
| Quick Ratio | 7.16 | ||
| Altman-Z | 11.39 |
F-Score5
WACC9.68%
ROIC/WACC2.56
Cap/Depr(3y)3.97%
Cap/Depr(5y)5.06%
Cap/Sales(3y)0.02%
Cap/Sales(5y)0.02%
Profit Quality(3y)114.75%
Profit Quality(5y)97.54%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.68%
EPS 3Y-3.27%
EPS 5YN/A
EPS Q2Q%-37.62%
EPS Next Y-16.66%
EPS Next 2Y45.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.83%
Revenue growth 3Y1.24%
Revenue growth 5Y39.04%
Sales Q2Q%-30.12%
Revenue Next Year-24.13%
Revenue Next 2Y21.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.37%
EBIT growth 3Y-7.73%
EBIT growth 5YN/A
EBIT Next Year-38%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-48.6%
FCF growth 3Y62.09%
FCF growth 5YN/A
OCF growth 1Y-48.56%
OCF growth 3Y61.9%
OCF growth 5YN/A